Bharat Biotech Completes Recruitment of 13,000 Volunteers for Phase III Trials of Covaxin

According to the company, the vaccine is developed and manufactured at Bharat Biotech's BSL-3, biocontainment facility.

from Top Business News- News18.com https://ift.tt/2WBIzJV

• Tweet
• Share
• Share
• Share
• Share